DC pole | Wartość | Język |
dc.contributor.author | Blukacz, Mateusz | - |
dc.contributor.author | Wachsmann, Agnieszka | - |
dc.contributor.author | Maga, Mikołaj | - |
dc.contributor.author | Schönborn, Martyna | - |
dc.contributor.author | Olszewska, Marta | - |
dc.contributor.author | Cebeńko, Małgorzata | - |
dc.contributor.author | Trynkiewicz, Agnieszka | - |
dc.contributor.author | Maga, Paweł | - |
dc.date.accessioned | 2020-02-14T12:08:22Z | - |
dc.date.available | 2020-02-14T12:08:22Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | "Folia Medica Cracoviensia" Vol. 59, no 1 (2019), s. 49-60 | pl_PL |
dc.identifier.issn | 0015-5616 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12128/12595 | - |
dc.description.abstract | I n t r o d u c t i o n: Peripheral arterial occlusive disease (PAOD) is a disease with worldwide
increasing occurrence. Diabetic patients are greatly exposed on the risk of PAOD and its complications.
Th e aim of the study was to check the infl uence of preoperative HbA1C on the outcomes of patients with
diabetes undergoing PAOD related endovascular treatment.
Mat e r i a l a n d Me t h o d s: Th e study was conducted among 59 patients with PAOD referred from
the diabetic foot outpatient for endovascular treatment. Th ey were included in one-year observation based
on follow-up visits in 1, 3, 6 and 12 months aft er angioplasty and divided into 2 groups basing on their
preoperative glycaemia. Th e clinical condition of the lower limbs was assessed by use of the Rutherford
classifi cation, ankle-brachial index (ABI) and toe-brachial index (TBI). Changes in patients’ quality of
life (QoL) were also evaluated.
R e s u l t s: Reintervention within 12 months were less frequent in patients with HbA1C ≤8.0% than in
HbA1C >8.0% patients (9.09% vs. 35.48%, p = 0.03). TBI of the treated limb was lower in patients with
elevated than in patients with proper glycaemia at 6 month [0.2 (0.0–0.38) vs. 0.38 (0.31–0.46); p <0.008]
50 Agnieszka Wachsmann, Mikołaj Maga, et al.
and 12 month follow-up [0.17 (0.0–0.27) vs. 0.32 (0.25–0.38); p <0,001]. Th e rate of healed ulcerations
aft er 6 months was higher in patients HbA1C ≤8.0% (45.0% vs. 16.13%; p = 0.02) and they had signifi cantly
greater improvement of QoL.
C on c l u s i o n: Results of this study shows that preoperative level of glycaemia is an important factor
for long-term prognosis in diabetic patients with PAOD. Elevated HbA1C level decreases signifi cantly
long-term improvement of QoL in DM patients undergoing endovascular treatment. | pl_PL |
dc.language.iso | en | pl_PL |
dc.rights | Uznanie autorstwa-Użycie niekomercyjne-Bez utworów zależnych 3.0 Polska | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/pl/ | * |
dc.subject | peripheral arterial occlusive disease | pl_PL |
dc.subject | diabetes mellitus | pl_PL |
dc.subject | HbA1C | pl_PL |
dc.subject | quality of life | pl_PL |
dc.subject | endovascular treatment | pl_PL |
dc.title | Impact of pre-operative glycated haemoglobin A1C level on 1-year outcomes of endovascular treatment in patients with critical limb ischemia in the course of diabetes mellitus | pl_PL |
dc.type | info:eu-repo/semantics/article | pl_PL |
dc.identifier.doi | 10.24425/fmc.2019.128025 | - |
Pojawia się w kolekcji: | Artykuły (WNS)
|